EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Tsunu-associated rapé use as a novel trigger in reversible cerebral vasoconstriction syndrome of synergistic vasoactive exposure: a case report

Marcelo Moraes Valença, Rita Santana dos Reis, Mario Fernando Prieto Peres, Juliana Ramos de Andrade

Headache Medicine · 03.08.2026 · 17 (2) · 174-178

DOI: 10.48208/headachemed.2026.22 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Headache Medicine, online erschienen am 03.08.2026. Verfasst von Marcelo Moraes Valença und 3 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IntroductionReversible cerebral vasoconstriction syndrome (RCVS) is characterized by recurrent thunderclap headaches and transient segmental narrowing of cerebral arteries, often precipitated by exposure to vasoactive substances. While several pharmacological and recreational agents have been implicated, traditional indigenous preparations such as tsunu-based rapé remain unexplored.Case presentationA 29-year-old man presented with 20 days of recurrent thunderclap headaches, including sex-triggered episodes. Neuroimaging revealed segmental vasoconstriction in the left anterior cerebral artery and right middle cerebral artery M1 segment. Exposures included escitalopram, methylphenidate, cannabis, sumatriptan, and regular tsunu-containing rapé, first headache during rapé inhalation.ConclusionAlthough direct causality cannot be established, this case raises the hypothesis that tsunu-based preparations, particularly when combined with other vasoactive substances, may contribute to cerebral vascular dysregulation. This report highlights the importance of recognizing non-conventional exposures in the evaluation of RCVS and suggests a potential novel trigger that warrants further investigation.

Zitieren

APA

Valença, M. M., Reis, R. S. D., Peres, M. F. P., & Andrade, J. R. D. (2026). Tsunu-associated rapé use as a novel trigger in reversible cerebral vasoconstriction syndrome of synergistic vasoactive exposure: a case report. Headache Medicine, 17(2), 174-178. https://doi.org/10.48208/headachemed.2026.22

Vancouver

Valença MM, Reis RSD, Peres MFP, Andrade JRD. Tsunu-associated rapé use as a novel trigger in reversible cerebral vasoconstriction syndrome of synergistic vasoactive exposure: a case report. Headache Medicine. 2026;17(2):174-178. doi:10.48208/headachemed.2026.22

BibTeX
@article{Valena2026,
  author = {Valença, Marcelo Moraes and Reis, Rita Santana dos and Peres, Mario Fernando Prieto and Andrade, Juliana Ramos de},
  title = {Tsunu-associated rapé use as a novel trigger in reversible cerebral vasoconstriction syndrome of synergistic vasoactive exposure: a case report},
  journal = {Headache Medicine},
  year = {2026},
  volume = {17},
  number = {2},
  pages = {174--178},
  doi = {10.48208/headachemed.2026.22}
}
Kostenlos starten →